Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis

Abstract

Background Despite widespread use of intrapartum antibiotic prophylaxis, group B streptococcus remains a leading cause of morbidity and mortality in infants in Europe, the Americas, and Australia. However, estimates of disease burden in many countries outside of these regions is not available. We aimed to examine the current global burden of invasive disease and the serotype distribution of group B streptococcus isolates.Methods We searched Medline, Embase, and Wholis databases for studies on invasive early-onset (day 0-6) and late-onset (day 7-89) group B streptococcal disease. Eligible studies were those that described incidence, deaths, or serotypes. We also reviewed reference lists and contacted experts to seek unpublished data and data missed by our search. Random effects meta-analysis was used to pool data.Findings 74 studies met the inclusion criteria; 56 studies reported incidence, 29 case fatality, and 19 serotype distribution. An additional search for studies that reported serotype distribution from Jan 1, 1980, yielded a total of 38 articles. Only five low-income countries were represented in the review and contributed 5% weight to the meta-analysis. 47 (69%) studies reported use of any intrapartum antibiotic prophylaxis. Substantial heterogeneity existed between studies. Mean incidence of group B streptococcus in infants aged 0-89 days was 0·53 per 1000 livebirths (95% CI 0·44-0·62) and the mean case fatality ratio was 9·6% (95% CI 7·5-11·8). Incidence of early-onset group B streptococcus (0·43 per 1000 livebirths [95% CI 0·37-0·49]) and case fatality (12·1%, [6·2-18·3]) were two-times higher than late-onset disease. Serotype III (48·9%) was the most frequently identified serotype in all regions with available data followed by serotypes Ia (22·9%), Ib (7·0%), II (6·2%), and V (9·1%). Studies that reported use of any intrapartum antibiotic prophylaxis were associated with lower incidence of early-onset group B streptococcus (0·23 per 1000 livebirths [95% CI 0·13-0·59]) than studies in which patients did not use prophylaxis (0·75 per 1000 livebirths [0·58-0·89]).Interpretation More high-quality studies are needed to accurately estimate the global burden of group B streptococcus, especially in low-income countries. A conjugate vaccine incorporating five serotypes (Ia, Ib, II, III, V) could prevent most global group B streptococcal disease.Funding Child Epidemiology Reference Group (CHERG), WHO.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(11)61651-6

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 91 references

Research works printed but not linked: 2

  1. Lea, 2004, Screening of hemolytical streptococcus of group B in pregnancy and prevention of infection in newborns, Ceska Gynekologie, 69, 91
  2. Stoll, 2011, Early onset neonatal sepsis: the burden of group B streptococcal and E. coli Disease Continues, Pediatrics, 127, 817, 10.1542/peds.2010-2217 · DOI · Paper page

Cited by

See all 675

Metadata

Authors
Edmond, K. M., Kortsalioudaki, C., Scott, S., Schrag, S. J., Zaidi, A. K., Cousens, S., & Heath, P. T.
Affiliations
  • London School of Hygiene & Tropical Medicine (GB)
  • St George's Hospital (GB)
  • Centers for Disease Control and Prevention (US)
  • Aga Khan University (PK)
  • University of London (GB)
Corresponding author
Edmond, Karen M
Venue
The Lancet
Publisher
Elsevier BV
Published
2012-02
Volume
379
Issue
9815
Pages
547-556
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2136755398
Cited by
600
References
91
Citations by year
2026: 13 · 2025: 17 · 2024: 30 · 2023: 24 · 2022: 26 · 2021: 54 · 2020: 34 · 2019: 54 · 2018: 60 · 2017: 67 · 2016: 62 · 2015: 60 · 2014: 36 · 2013: 38 · 2012: 25
FWCI
7.84
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • eCommons - AKU (Aga Khan University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
  • Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
Streptococcus agalactiae, early-onset neonatal infection, late-onset neonatal infection, disease burden, incidence, case fatality, serotype distribution, serotype 3, intrapartum antibiotic prophylaxis, low-income countries, infants under 3 months, global burden of disease
MeSH terms
Humans, Infant, Infant, Newborn, Risk Factors, Serotyping, Streptococcal Infections, Streptococcus agalactiae, Incidence, Antibiotic Prophylaxis, Streptococcal Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(11)61651-6
The paper
Edmond, K. M., Kortsalioudaki, C., Scott, S., Schrag, S. J., Zaidi, A. K., Cousens, S., & Heath, P. T. (2012). Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. The Lancet. https://doi.org/10.1016/s0140-6736(11)61651-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.